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5. Partial mastectomy combined with axillary dissection may be justifiable
in occasionalearly cases with small growths, but is unjustifiable as a routine owing
to the danger oflocal recurrence.
6. Simple mastectomy combined with irradiation to the axilla may give a
satisfactory result, but the irradiation is generally more upsetting to the patient
than surgical dissection of the axilla.
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ONE of the implications underlying the work of Huggins and Hodges (1941)
on the factors governing prostatic hypertrophy is that malignant prostatic cells
are not fully, if at all, autonomous. That is, they are still controlled in some
measure by the same factors that control normal prostatic cells. Specifically,
this is certainly true of their susceptibility to the influence of circulating
androgens and oestrogens.
Carcinoma of the prostate is essentially a disease of old age. The possibility
exists that the chief factor in deciding the individual's susceptibility to this
disease may be his androgenic state, that is, the level of circulating androgens in
his blood, particularly during the later decades of life.
The only practical method for ascertaining androgenic state is a determination
of 17-ketosteroids excreted in the urine of the subject. In the hands of many
different workers (Barnett, Henly, Morris and Warren, 1946) this method has
revealed a very wide range of excretion of 17-ketosteroids by normal men, at
least in the lower age-groups. An adult male may excrete in a range which is
at least 7-28 mg./day. It is clear that if such differences persist throuaghout lifeA. M. ROBINSON
the prostates of individuals who excrete at the higher or lower end of this scale
will be subjected to grossly different amounts of androgenic stimulation.
Most of the available data on the excretion of 17-ketosteroids is confined to
results obtained in studies of men under the age of 30-years. Although there is
a general impression that the excretion ofthese substances decreases with advanc-
ing age of the individual, there is a paucity of data on the range of excretion in
the higher age-groups.
The ideal method of study would be to make repeated determinations of the
17-ketosteroid output in a large number of individuals over a period of m%ny
years, until, in fact, the subjects did or did not develop prostatic cancer. An
alternative method, which has been adopted in the present work, is to compare
the androgenic status, as judged by 17-ketosteroid estimations, of known cases
of prostatic cancer with control values obtained on cancer-free subjects in the
sufferer's own age-group. The experiments described in this paper were carried
out for a two-fold purpose: Firstly, to obtain the control values necessary for
comparison with those of prostatic cancer cases. Secondly, to discover whether
the wide physiological range of excretion encountered in the lower age-groups
persists in old age. The existence ofsuch a range in old age might be a significant
fact in any consideration ofthe aetiology of the disease.
METHODS.
The subjects used in this work, 128 in all, were either normal men or hospital
patients suffering from diseases that do not affect the output of 17-ketosteroids.
No cases of endocrine disease were included. Surgical cases were included only
when the patients were in a late stage of convalescence and the effect ofoperative
trauma on the excretion of 17-ketosteroids had ceased to exist.
Complete 24-hour collections of urine were made and aliquots hydrolysed
and extracted according to the procedure of Robbie and Gibson (1943). The
total 17-ketosteroids were estimated by the method described by Callow, Callow
and Emmens (1938). The colorimetric measurements-were made on a Hilger
Spekker photoelectric absorptiometer using a green (Ilford Spectrum 604) and a
violet (Ilford Spectrum 601) light filter. From the readings taken with these
two filters a correction was made for the interfering chromogens in the urine
extracts according to the method of Talbot, Berman and MacLachlan (1942).
A parallel study of the validity of this colour correction which will be published
elsewhere (Morris, Robinson andWarren, 1948) showed that such colour-corrected
figures are a close approximation to the true 17-ketosteroid content. All the
results given in the present paper have been so corrected.
RESULTS.
Although attention was mainly directed to males over the age of 40 years,
since it is in this range of ages that chief interest lies from the point of view of
prostatic cancer, some younger subjects were included in the present study.
Fewer cases were investigated in this lower age-group, but the results obtained
are in general agreement with those found by other workers (Barnet, Henly,
Morris and Warren, 1946), and they are included in the summaries of all the
results given in Table I and Fig. 1.
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TABLE I.
Age group . . . 0-5 . 6-10 .11-15.16-20.21-30.31-40.41-50.51-60.61-70.71-80.81-90
Number of obs. . 3 3 . 3 . 2 . 13 . 11 . 29 .22 .28 . 12 . 2
Mean 17-K.S. mg./day . 0.7 . 5-8 . 7 9 .12.6 .14.1 .16.8 .11.0 . 77 . 7-8 . 6-4 . 43
a . . . ~~04 .2-9 .2-6 .1-3 .4-3 .7-2 .4-7 .3-5 .3-1 . 3 0 .1-2
E . . . ~~0-2 .1-7 .1-5 .0 9 .1-2 .2-2 .0-9 .0-8 .0-6 . 0 9 .0 9
Coeff. ofvar. per cent. 51 .50 .33 10 .30. 43. 43 .45 .40 . 47 .28
Range mean ± 2a. . 0-.0- .2 7-. 10- .5.5-. 2-4-. 1 6-. 0 7-. 1 6-. 0 4-. 1 9-
1-5 11-6 13-1 15-2 22-7 31-2 20-4 14-7 14-0 12-4 6-7
Summary of 17-ketosteroid excretions in normal males. a = Standard deviation; E = Standard
error. Coefficient ofvariation (per cent.) is a expressed as percentage of the mean value.
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FIG. 1.-Mean excretion of 17-ketosteroids by normal men of different ages.
DISCUSSION.
Fig. 1 clearly shows the distribution of excretion of 17-ketosteroids with age.
The output in childhood is low, rising rapidly at or about the age of puberty and
reaching a maximum in middle age. The small difference in mean excretions
between the third decade (14.1 mg./day) and the fourth decade (16.8 mg./day) is
probably notsignificant (P >0 05), butthe decreased excretion in the fifth decade
(mean value 11 0 mg./day) is significant (P<0 05).
Consideration of the coefficients of variation brings out the interesting point
that, although the general level of excretion decreases as age increases from 40
to 80 years, the scatter of individual excretions about the average value in any
age-group remains constant. Expressed as a percentage of the mean output,
men between 70 and 80 years ofage show just as much variation in their excretions
as men between 30 and 40. This is illustrated in Fig. 2, in which are plotted the
mean excretions for the third to the eighth decade, together with the upper and
lower limits of the ranges encountered at those ages. The ranges are computed
as the mean values + 2a.
The fact that men continue to show comparatively wide individual variations
in their outputs of 17-ketosteroids andhence, probably, in the degree ofandrogenic
stimulation to which their prostates are subjected, until veryadvanced age, must
obviously be taken into account in any consideration ofthe aetiology ofprostatic
cancer. It will clearly be of importance to know whether known sufferers from
this disease are characterized by excretions at the upper or lower ranges of their
appropriate age-groups, or whether they are not significantly distinguishable
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FIG. 2.-Range of excretion of 17-ketostQroids by normal men of different ages.
O Mean excretion.
+ Limit of upper range (mean + 2 a).
- Limit of lower range (mean - 2 a).
from the general population of those age-groups. An attempt to determine
which of these altematives is true is now in progress.
SUMMARY.
The excretion of 17-ketosteroids by normal men of all ages up to the ninth
decade has been determined.
Excretion is low in childhood, rises rapidly at or about the age of puberty,
and reaches a maximum in middle age. After the fourth decade there is a
gradual decline in output.
From the fourth to the eighth decade the coefficient of variation of the
excretion remains constant, and men between 70 and 80 years of age show just
as great an individual variation in output as men between 30 and 40.
The implications of these results for the problem of prostatic cancer is
discussed.
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